As we head into the second half of 2025, the Canadian market is closely monitoring developments in tariff and trade negotiations, particularly with the U.S. and China. Despite potential challenges from rising tariffs, opportunities remain for investors who can identify stocks with strong financial health. Penny stocks, often representing smaller or newer companies, may still offer significant growth potential when backed by solid fundamentals; in this article, we explore several such stocks that could present long-term value.
Top 10 Penny Stocks In Canada
| Name | Share Price | Market Cap | Rewards & Risks |
| PetroTal (TSX:TAL) | CA$0.70 | CA$631.14M | ✅ 3 ⚠️ 4 View Analysis > |
| Orezone Gold (TSX:ORE) | CA$1.31 | CA$706.92M | ✅ 4 ⚠️ 2 View Analysis > |
| Dynacor Group (TSX:DNG) | CA$4.50 | CA$191.4M | ✅ 4 ⚠️ 2 View Analysis > |
| Fintech Select (TSXV:FTEC) | CA$0.025 | CA$2.4M | ✅ 2 ⚠️ 3 View Analysis > |
| Findev (TSXV:FDI) | CA$0.435 | CA$12.6M | ✅ 2 ⚠️ 4 View Analysis > |
| Thor Explorations (TSXV:THX) | CA$0.80 | CA$505.63M | ✅ 3 ⚠️ 2 View Analysis > |
| NTG Clarity Networks (TSXV:NCI) | CA$2.24 | CA$93.5M | ✅ 4 ⚠️ 2 View Analysis > |
| Intermap Technologies (TSX:IMP) | CA$2.09 | CA$122.37M | ✅ 3 ⚠️ 2 View Analysis > |
| Hemisphere Energy (TSXV:HME) | CA$1.92 | CA$182.11M | ✅ 3 ⚠️ 1 View Analysis > |
| McChip Resources (TSXV:MCS) | CA$0.88 | CA$5.02M | ✅ 2 ⚠️ 4 View Analysis > |
Click here to see the full list of 885 stocks from our TSX Penny Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
BioRem (TSXV:BRM)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: BioRem Inc. is a clean technology engineering company that focuses on designing, manufacturing, distributing, and selling air pollution control systems to eliminate odors, volatile organic compounds, and hazardous air pollutants, with a market cap of CA$33.28 million.
Operations: The company generates CA$36.23 million in revenue from the manufacture and sale of pollution control systems.
Market Cap: CA$33.28M
BioRem Inc. has demonstrated financial resilience with a solid market cap of CA$33.28 million and revenue of CA$36.23 million, despite recent declines in quarterly earnings and net income compared to the previous year. The company maintains high-quality earnings, with a strong Return on Equity at 25.6% and operating cash flow well covering its debt obligations. BioRem's short-term assets exceed both its short- and long-term liabilities, indicating robust liquidity management. However, recent earnings have shown decreased profit margins from last year, highlighting potential challenges in sustaining growth amidst industry volatility.
- Click to explore a detailed breakdown of our findings in BioRem's financial health report.
- Gain insights into BioRem's outlook and expected performance with our report on the company's earnings estimates.
Empress Royalty (TSXV:EMPR)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Empress Royalty Corp. is involved in creating and investing in a portfolio of precious metal royalty and streaming interests in Canada, with a market cap of CA$78.48 million.
Operations: The company's revenue is primarily derived from the acquisition of mining royalty and streaming interests, totaling $9.80 million.
Market Cap: CA$78.48M
Empress Royalty Corp., with a market cap of CA$78.48 million, has transitioned to profitability this year, reporting net income of US$0.44 million for Q1 2025. The company is trading significantly below its estimated fair value and forecasts suggest revenue growth of 24.56% annually. Its short-term assets cover both short- and long-term liabilities, indicating sound financial health, while the debt is well covered by operating cash flow. However, the Return on Equity remains low at 11%, and interest payments are not adequately covered by EBIT, suggesting potential challenges in managing interest obligations effectively.
- Dive into the specifics of Empress Royalty here with our thorough balance sheet health report.
- Assess Empress Royalty's future earnings estimates with our detailed growth reports.
Royal Road Minerals (TSXV:RYR)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Royal Road Minerals Limited is involved in the exploration and development of mineral properties across the Kingdom of Saudi Arabia, Morocco, Jersey, and South America, with a market cap of CA$33.21 million.
Operations: There are no reported revenue segments for Royal Road Minerals Limited.
Market Cap: CA$33.21M
Royal Road Minerals Limited, with a market cap of CA$33.21 million, is pre-revenue and currently unprofitable. The company remains debt-free and has sufficient cash runway for over a year based on its current free cash flow. Recent strategic developments include the establishment of a Special Advisory Board and an option agreement to acquire the Lalla Aziza copper mine in Morocco, which could enhance future prospects if exploration proves successful. However, auditors have expressed concerns about its ability to continue as a going concern due to ongoing losses, highlighting financial instability despite potential growth opportunities from new projects.
- Click here and access our complete financial health analysis report to understand the dynamics of Royal Road Minerals.
- Review our historical performance report to gain insights into Royal Road Minerals' track record.
Where To Now?
- Click here to access our complete index of 885 TSX Penny Stocks.
- Ready To Venture Into Other Investment Styles? Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Empress Royalty might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com